Paid Clinical Trials Jersey City
Discover 1,568 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)
Sponsor:
Boston Children's Hospital
Location:
Code:
NCT05600426
Conditions
Severe Aplastic Anemia
Eligibility Criteria
Sex: All
Age: 0 - 25
Healthy Volunteers: Not accepted
Interventions
cyclosporine
Matched Unrelated Donor Hematopoetic Stem Cell Transplant
horse anti-thymocyte globulin (ATG)
rabbit anti-thymocyte globulin (ATG)
Methotrexate
Non-invasive Brain Stimulation in Children With AutismNon-invasive Brain Stimulation in Children With Autism
Sponsor:
Rutgers, The State University of New Jersey
Location:
Code:
NCT05105126
Conditions
Autism Spectrum Disorder
Executive Dysfunction
Child Autism
Eligibility Criteria
Sex: All
Age: 5 - 12
Healthy Volunteers: Not accepted
Interventions
Transcranial Direct Current Stimulation (tDCS)
Sham tDCS
A Study of Response to Standard Treatment Before Surgery in People With Rectal CancerA Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT06637462
Conditions
Rectal Cancer
Adenocarcinoma of the Rectum
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Endoscopy
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Sponsor:
Chimerix
Location:
Code:
NCT05580562
Conditions
H3 K27M
Glioma
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Dordaviprone (ONC201)
Dordaviprone (ONC201) + Placebo
Placebo
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid ArthritisA Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis
Sponsor:
Immunovant Sciences GmbH
Location:
Code:
NCT06754462
Conditions
Rheumatoid Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
IMVT-1402
Placebo
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your JobTalking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT03572374
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TEAMWork App
Information Booklet
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without IbalizumabA Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
Sponsor:
Theratechnologies
Location:
Code:
NCT05388474
Conditions
HIV Infections
Multi-Antiviral Resistance
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
No ibalizumab or Pre-ibalizumab treatment
On ibalizumab treatment
Clinical Application of Stem Cell Educator Therapy in Type 1 DiabetesClinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
Sponsor:
Throne Biotechnologies Inc.
Location:
Code:
NCT04011020
Conditions
Type 1 Diabetes
Eligibility Criteria
Sex: All
Age: 14+
Healthy Volunteers: Not accepted
Interventions
Stem Cell Educator therapy
Brain Activity in People With Chronic Neuropathic Pain and Spinal Cord InjuryBrain Activity in People With Chronic Neuropathic Pain and Spinal Cord Injury
Sponsor:
Kessler Foundation
Location:
Code:
NCT04386174
Conditions
Neuropathic Pain
Spinal Cord Injury
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Neurofeedback
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or LegA Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT04332874
Conditions
Sarcoma
Myxofibrosarcoma
Undifferentiated Pleomorphic Sarcoma
Alveolar Soft Part Sarcoma
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Isolated Limb Infusion
Pembrolizumab
infusion of melphalan and dactinomycin